
Traws Pharma, Inc.
TRAWHealthcare|Biotechnology|US
$0.22
+0.00 (+0.82%)
Cash / Share
$0.29
Next Earnings Report
Nov 12, 2026
EPS est. -$0.21 · Revenue est. $2.7M
Financing Filings (last 12 months)
6
Shelf registrations / offering prospectuses — latest Oct 26, 2026 (S-1). Possible dilution.
Upcoming Data Readouts (1)
Dec 2026
Est. completion
P2Influenza
This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Tivoxavir Marboxil in Patients With Mild to Moderate Influenza
NCT07371650n=105
Recent Press Releases
Traws Pharma Reports Q2 2026 Financial Results and Provides Business Highlights
Aug 14, 2026 · GlobeNewsWire
SEC Filings (113)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 5, 2026 | D | DocumentIndex | |
| Oct 26, 2026 | S-1 | IPO / offering registration | DocumentIndex |
| Oct 23, 2026 | 8-K | Material event | DocumentIndex |
| Oct 20, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Oct 20, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Oct 8, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Aug 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 14, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 14, 2026 | 8-K | Material event | DocumentIndex |
| Aug 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 14, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Aug 12, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jul 31, 2026 | 8-K | Material event | DocumentIndex |
| Jul 10, 2026 | 8-K | Material event | DocumentIndex |
| Jul 10, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Jul 9, 2026 | EFFECT | DocumentIndex | |
| Jul 9, 2026 | 8-K | Material event | DocumentIndex |
| Jul 1, 2026 | S-3 | Shelf registration | DocumentIndex |
| Jun 22, 2026 | 8-K | Material event | DocumentIndex |
| Jun 12, 2026 | 8-K | Material event | DocumentIndex |
| May 29, 2026 | ARS | Annual report to holders | DocumentIndex |
| May 29, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| May 29, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| May 27, 2026 | 8-K | Material event | DocumentIndex |
| May 26, 2026 | 8-K | Material event | DocumentIndex |
| May 22, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| May 19, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| May 15, 2026 | EFFECT | DocumentIndex | |
| May 15, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 15, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 15, 2026 | 8-K | Material event | DocumentIndex |
| May 8, 2026 | S-3 | Shelf registration | DocumentIndex |
| May 5, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Apr 30, 2026 | 10-K/A | Annual report | DocumentIndex |
| Apr 15, 2026 | 10-K | Annual report | DocumentIndex |
| Apr 15, 2026 | 8-K | Material event | DocumentIndex |
| Apr 15, 2026 | 8-K | Material event | DocumentIndex |
| Mar 31, 2026 | NT 10-K | DocumentIndex |